Document Details

Generated Narrative: Bundle TEST PURPOSES ONLY - koselugo

Document Subject

Generated Narrative: MedicinalProductDefinition mp4a0e2349adfb2620b1fba9cd50d81a0a

identifier: http://ema.europa.eu/identifier/EU/1/21/1552/001 10 mg hard capsules

type: Medicinal Product

domain: Human use

status: active

legalStatusOfSupply: Medicinal product subject to medical prescription

name

productName: Koselugo 10 mg hard capsules

type: Full name

part

part: nan

type: Invented name part

part

part: nan

type: Scientific name part

part

part: nan

type: Strength part

part

part: nan

type: Pharmaceutical dose form part

Usages

-	Country	Jurisdiction	Language
*	EU	EU	en

Document Content

Generated Narrative: Composition composition-en-4a0e2349adfb2620b1fba9cd50d81a0a

identifier: http://ema.europa.eu/identifier/EU/1/21/1552/001 10 mg hard capsules

status: Final

type: Package Leaflet

category: Raw

date: 2022-02-16 13:28:17+0000

author: Organization ACME industry

title: TEST PURPOSES ONLY - koselugo

Attesters

What is in this leaflet

1. What Koselugo is and what it is used for
2. What you need to know before you take Koselugo
3. How to take Koselugo
4. Possible side effects
5. How to store Koselugo
6. Contents of the pack and other information

What Koselugo is and how it works Koselugo contains the active substance selumetinib. Selumetinib is a type of medicine called a MEK inhibitor. It works by blocking certain proteins involved in the growth of tumour cells. Koselugo is expected to shrink tumours that grow along nerves, called plexiform neurofibromas. These tumours are caused by a genetic condition called neurofibromatosis type 1 (NF1). What Koselugo is used for Koselugo is used to treat children aged 3 years and above with plexiform neurofibromas that cannot be completely removed by surgery. If you have any questions about how Koselugo works or why this medicine has been prescribed for you, ask your doctor.

Do not take Koselugo:

if you are allergic to selumetinib or any of the other ingredients of this medicine (listed in section 6)

if you have severe liver disease If you are not sure, talk to your doctor, pharmacist or nurse before taking Koselugo. Warnings and precautions Talk to your doctor, pharmacist or nurse before and during your treatment with Koselugo:

if you have eye problems

if you have heart problems

if you have liver problems

if you take supplements containing vitamin E

if you cannot swallow the capsule whole If any of the above apply to you (or you are not sure) talk to your doctor, pharmacist or nurse before taking this medicine. Eye problems Koselugo can cause eye problems (see section 4 Possible side effects ). Tell your doctor straight away if you get blurred vision or any other changes to your sight during treatment. Your doctor should examine your eyes if you have any new or worsening problems with your sight while you are taking this medicine. Heart problems Koselugo can lower the amount of blood pumped by your heart (see section 4 Possible side-effects ). Your doctor will check how well your heart works before and during your treatment with Koselugo. Liver problems Koselugo can increase the amount of some liver enzymes in your blood (see section 4 Possible side effects ). Your doctor will do blood tests before and during treatment to check how well your liver is working. Supplemental vitamin E Koselugo capsules contain vitamin E that may increase your risk of bleeding. This means you should tell your doctor if you take other medicines that increase your risk of bleeding such as:

acetylsalicylic acid (also known as aspirin) for pain and inflammation

anticoagulant medicines (blood thinners) such as warfarin or other medicines used for preventing blood clots

supplements that may increase your risk of bleeding, such as vitamin E Difficulty swallowing capsules Talk to your doctor if you think you might have difficulties swallowing the capsules whole (see section 3 How to take Koselugo ).
Skin, nail and hair problems Koselugo can cause skin rash, nail infection or hair thinning or changes in hair colour (see section 4 Possible side effects ). Tell your doctor if any of these symptoms trouble you during treatment. Children under 3 years old Do not give Koselugo to children below 3 years of age. This is because it has not been studied in this age group. Other medicines and Koselugo Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes herbal medicines, supplements and medicines obtained without a prescription. Koselugo can affect the way some other medicines work. Also, some other medicines can affect the way Koselugo works. Tell your doctor if you are taking any of the following medicines:

clarithromycin or erythromycin (used to treat bacterial infections)

carbamazepine or phenytoin (used to treat seizures and epilepsy)

digoxin (used to treat heart failure)

fexofenadine (used to treat symptoms of allergy)

fluconazole or itraconazole (used to treat fungal infections)

ketoconazole (used to treat Cushing s syndrome)

furosemide (used to treat fluid retention by increasing the amount of urine you pass)

methotrexate (used to treat some types of cancer, psoriasis or rheumatoid arthritis)

omeprazole (used to treat acid reflux or stomach ulcer)

rifampicin (used to treat tuberculosis (TB) and some other bacterial infections)

St. John s wort (Hypericum perforatum), a herbal medicine (used to treat mild depression and other conditions)

ticlopidine (used to prevent blood clots) Tell your doctor or pharmacist if you are taking or have recently taken any of the above or any other medicines, even those that are not prescribed. Koselugo with food and drink Do not drink grapefruit juice while you are taking Koselugo because, it can affect the way the medicine works. Pregnancy information for women Koselugo is not recommended during pregnancy. It may cause harm to an unborn baby. If you think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Your doctor may ask you to take a pregnancy test before starting treatment. You should not become pregnant while taking this medicine. If you are able to become pregnant, you must use effective contraception. See Contraception - information for women and men below. If you become pregnant during treatment, tell your doctor straight away. Pregnancy information for men If your partner becomes pregnant while you are taking this medicine, tell your doctor straight away. Contraception information for women and men If you are sexually active you should use effective contraception while you are taking this medicine and for at least 1 week after the last dose. It is not known whether Koselugo may interfere with how well hormonal contraceptives work. Please tell your doctor if you are taking a hormonal contraceptive, as your doctor may recommend the addition of a non-hormonal method of birth control. Breast-feeding Do not breast-feed if you are taking Koselugo. It is not known if Koselugo passes into breast milk. Driving and using machines Koselugo can cause side effects that affect your ability to drive or use machines. Do not drive or use machines if you feel tired or if you have problems with your vision (such as blurred vision).

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. How much to take Your doctor will work out the correct dose for you based on your height and weight. The doctor will tell you how many capsules of Koselugo to take. Your doctor may prescribe a lower dose if you have problems with your liver (hepatic impairment). Your doctor may reduce your dose if you have certain side effects while you are taking Koselugo (see section 4 Possible side effects ) or the doctor may interrupt treatment or stop it permanently. How to take

Take Koselugo twice a day, about 12 hours apart, with or without food.

Swallow the capsules whole with water.

Do not chew, dissolve, or open the capsules.

If you have, or think you might have difficulty swallowing capsules whole, talk to your doctor before starting treatment.
If you are sick If you are sick (vomit) at any time after taking Koselugo, do not take an extra dose. Take the next dose at the normal time. If you take more Koselugo than you should If you have taken more Koselugo than you should, contact your doctor or pharmacist immediately. If you forget to take Koselugo What to do if you forget to take a dose of Koselugo depends on how long it is until your next dose.

If it is more than 6 hours until your next dose, take the missed dose. Then take the next dose at the normal time.

If it is less than 6 hours until your next dose, skip the missed dose. Then take the next dose at the normal time. Do not take a double dose (two doses at the same time) to make up for a forgotten dose. If you stop taking Koselugo Do not stop taking Koselugo unless your doctor tells you. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

Like all medicines, this medicine can cause side effects, although not everybody gets them. Possible serious side effects Eye (vision) problems Koselugo can cause eye problems. Tell your doctor straight away if you get blurred vision (a very common side effect that may affect more than 1 in 10 people) or any other changes to your sight during treatment. Your doctor may ask you to stop taking this medicine or send you to a specialist, if you develop symptoms that include:

blurred vision

loss of vision

dark spots in your vision (floaters)

other changes to your vision (such as reduced vision) Tell your doctor straight away if you notice any of the serious side effects above. Other side effects Tell your doctor or pharmacist if you notice any of the following side effects: Very common (may affect more than 1 in 10 people)

being sick (vomiting), feeling sick (nausea)

diarrhoea

inflammation of the mouth (stomatitis)

skin and nail problems - signs may include dry skin, rash, redness around the fingernails

hair thinning (alopecia), hair colour change

feeling tired, weak or lacking energy

fever (pyrexia)

swelling of the hands or feet (peripheral oedema)

a slight decrease in the amount of blood that the heart is pumping (ejection fraction decreased)
signs may include shortness of breath or swelling in your legs, ankles or feet

high blood pressure (hypertension)

reduced level of albumin, an essential protein in the blood (shown in blood tests)

reduced haemoglobin, the oxygen-carrying protein in red blood cells (shown in blood tests)

increase in enzymes (shown in blood tests) suggesting stress on the liver, kidney injury or muscle breakdown Common (may affect up to 1 in 10 people)

dry mouth

swelling of the face (facial oedema)

shortness of breath (dyspnoea) Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and carton after EXP. The expiry date refers to the last day of that month. Do not store above 30 C. Store in the original bottle in order to protect from moisture and light. Keep the bottle tightly closed. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

What Koselugo contains The active substance is selumetinib. Each Koselugo 10 mg hard capsule contains 10 mg of selumetinib (as hydrogen sulfate). Each Koselugo 25 mg hard capsule contains 25 mg of selumetinib (as hydrogen sulfate). The other ingredients in Koselugo 10 mg hard capsules are:

capsule fill: vitamin E polyethylene glycol succinate (D -tocopheryl polyethylene glycol succinate).

capsule shell: hypromellose (E464), carrageenan (E407), potassium chloride (E508), titanium dioxide (E171), carnauba wax (E903).

printing ink: shellac standard (E904), iron oxide black (E172), propylene glycol (E1520) ammonium hydroxide (E527). The other ingredients in Koselugo 25 mg hard capsules are:

capsule fill: vitamin E polyethylene glycol succinate (D -tocopheryl polyethylene glycol succinate).

capsule shell: hypromellose (E464), carrageenan (E407), potassium chloride (E508), titanium dioxide (E171), indigo carmine aluminium lake (E132), iron oxide yellow (E172), carnauba wax (E903), maize starch.

printing ink: iron oxide red (E172), iron oxide yellow (E172), indigo carmine aluminium lake (E132), carnauba wax (E903), shellac, standard (E904), glyceryl mono-oleate. What Koselugo looks like and contents of the pack Koselugo 10 mg hard capsule is a white to off-white, opaque, hard capsule which has a centre band and is marked with SEL 10 in black ink. Koselugo 25 mg hard capsule is a blue, opaque, hard capsule which has a centre band and is marked with SEL 25 in black ink. Koselugo is provided in white plastic bottles, capped with a white (10 mg) or blue (25 mg) child- resistant closure containing 60 hard capsules and a silica gel desiccant. Do not remove the desiccant from the bottle and do not swallow it. Marketing Authorisation Holder AstraZeneca AB SE-151 85 S dert lje Sweden Manufacturer AstraZeneca AB Karlebyhusentr n Astraall n SE-152 57 S dert lje Sweden For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: Belgi /Belgique/Belgien Alexion Pharma Belgium Tel: +32 800 200 Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660

.: +359 24455Luxembourg/Luxemburg Alexion Pharma Belgium T l/Tel: +32 800 200 esk republika AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 Magyarorsz g AstraZeneca Kft. Tel.: +36 1 883 6Danmark AstraZeneca A/S Tlf: +45 43 66 64 Malta Associated Drug Co. Ltd Tel: +356 2277 8Deutschland AstraZeneca GmbH Tel: +49 40 809034Nederland AstraZeneca BV Tel: +31 85 808 9Eesti AstraZeneca Tel: +372 6549 Norge AstraZeneca AS Tlf: +47 21 00 64
AstraZeneca A.E. : +30 210 6871 sterreich AstraZeneca sterreich GmbH Tel: +43 1 711 31 0 Espa a Alexion Pharma Spain, S.L. Tel: +34 93 272 30 Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 France Alexion Pharma France SAS T l: +33 1 47 32 36 Portugal Alexion Pharma Spain, S.L. - Sucursal em Portugal Tel: +34 93 272 30 Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 Rom nia AstraZeneca Pharma SRL Tel: +40 21 317 60 Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7Slovenija AstraZeneca UK Limited Tel: +386 1 51 35 sland Vistor hf. S mi: +354 535 7Slovensk republika AstraZeneca AB, o.z. Tel: +421 2 5737 7Italia Alexion Pharma Italy srl Tel: +39 02 7767 9Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23

: +357 22490Sverige AstraZeneca AB Tel: +46 8 553 26 Latvija SIA AstraZeneca Latvija Tel: +371 67377United Kingdom (Northern Ireland) AstraZeneca UK Ltd Tel: +44 1582 836 This leaflet was last revised in This medicine has been given conditional approval . This means that there is more evidence to come about this medicine. The European Medicines Agency will review new information on this medicine at least every year and this leaflet will be updated as necessary. Other sources of information Detailed information on this medicine is available on the European Medicines Agency web site: